Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial...
Tempus, a leader in artificial intelligence and precision medicine, announced that the company has signed an agreement for in-network provider status with Cigna Healthcare....
Transformative, instrument-free solution for single cell RNA sequencing updated with improved sensitivity, faster workflow
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing...
Andor Health, the AI company reimagining virtual care, expands its partnership with Cincinnati Children's to power Virtual Visits and Digital Front Door capabilities.
Cincinnati Children's, the #1...
The research demonstrates a breakthrough in applying quantum-enhanced generative AI to drug discovery using today’s quantum devices.
Zapata Computing, Inc., the Industrial Generative AI company,...
Ryght, an innovator in generative artificial intelligence (GenAI) technology for the life science industry, announced a strategic partnership with Avance Clinical, the largest specialist...
Seeking to harness the transformative power of Artificial Intelligence (AI) to safely enhance patient care, Hartford HealthCare has unveiled its Center for AI Innovation in...
Perimeter Medical Imaging AI, Inc. – a commercial-stage medical technology company – announced results from a new study published in the Annals of Surgical...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X,...